1. Home
  2. Live Updates
  3. கேம்பிரிட்ஜ் நிறுவனம் க்கு மருத்துவ ஆராய்ச்சி

கேம்பிரிட்ஜ் நிறுவனம் க்கு மருத்துவ ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கேம்பிரிட்ஜ் நிறுவனம் க்கு மருத்துவ ஆராய்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கேம்பிரிட்ஜ் நிறுவனம் க்கு மருத்துவ ஆராய்ச்சி Today - Breaking & Trending Today

ICYMI: Feel-good stories from around the world | News | DW


New malaria vaccine could be game changer
Chloe Zhao makes history at Oscars
Nomadland, becoming the first Asian woman, the first woman of color and the second woman in the Oscar s 93-year history to win the prize.
Nomadland follows the story of a woman who embarks on a journey through the American West, living out of her van.
Born in Beijing, Zhao s own journey took her to the Badlands of Wyoming, then to Los Angeles before becoming one of the most in-demand directors in show business.
The Chinese-born Chloe Zhao won best director and best picture for Nomadland in a history-making Oscars sweep ....

Burkina Faso , New York , United States , United Kingdom , San Diego , Region Des Hauts Bassins , Georgia General , Steve Mccurry , Wayne Miller , Matt Groening , Fred Flintstone , Cristina Carcia Rodero , Eve Arnold , Dennis Stock , Inge Morath , David Hurn , Los Angeles , Julian Rayner , Richard Kalvar , Thomas Hoepker , Jean Gaumy , Chloe Zhao Oscar , Martin Parr , Jayne Mansfield , Harry Gruyaert , Chloe Zhao ,

New malaria vaccine first to reach WHO efficacy demand | Science| In-depth reporting on science and technology | DW


New malaria vaccine first to reach WHO efficacy demand
Malaria kills hundreds of thousands of children each year. Now, an early stage malaria vaccine trial in Africa has shown encouraging results.
A malaria vaccine trial in Burkina Faso has shown promising results for the fight against the disease, which killed more than 400,000 people in 2019.
The results of the trial, published on Preprints with The Lancet and currently awaiting peer review, showed that the R21/Matrix-M vaccine had 77% efficacy over 12 months of follow-up. 
It is the first vaccine to meet the World Health Organization s (WHO) Malaria Vaccine Technology Roadmap goal of a vaccine with at least 75% efficacy. ....

Burkina Faso , United Kingdom , Julian Rayner , Cambridge Institute For Medical Research , University Of Cambridge , World Health Organization , Malaria Vaccine Technology Roadmap , Cambridge Institute , Medical Research , புர்கினா ஃபாஸொ , ஒன்றுபட்டது கிஂக்டம் , ஜூலியன் ரேநர் , கேம்பிரிட்ஜ் நிறுவனம் க்கு மருத்துவ ஆராய்ச்சி , பல்கலைக்கழகம் ஆஃப் கேம்பிரிட்ஜ் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , கேம்பிரிட்ஜ் நிறுவனம் , மருத்துவ ஆராய்ச்சி ,